Biomedicals is looking at expanding into making rapid PCR tests for viruses. Currently, they have 8,000 shares outstanding and $1,000,000 in debt with an interest rate of 6%. The expansion will cost $1,500,000 million. They are looking at two options for financing the expansion. Issue $1,500,000 in shares at a price of $20 per share Issue debt at a rate of 6% Calculate the indifference point in terms if EBIT for the two options?